Journal der Deutschen Dermatologischen Gesellschaft

Journal Abbreviation: J DTSCH DERMATOL GES
ISSN: 1610-0387
eISSN: 1610-0379
Publisher: Wiley-Blackwell

Publications (313)

close-button

Types of publications

Journal article
Unpublished / Preprint

Publication year

From
To

Abstract

Step-by-step Improvement of mRNA-electroporated dendritic Cells in a Phase I / II Clinical Study in cutaneous Melanoma Patients: better Survival correlates with a higher Immunoscore and increased Expression of PEBP1 in the Blood (2020) Dörrie J, Schaft N, Gross S, Ostalecki C, Eberhardt M, Vera-Gonzales J, Uslu U, et al. Conference contribution Malignant Tumors as important Differential Diagnosis of chronic Ulcers (2020) Toussaint F, Erdmann M, Berking C, Erfurt-Berge C Conference contribution Detection and Assessment of epidermotropic, pigmented Melanoma Metastases under Therapy using 3D Whole-Body Photography (2020) Erdmann M, Toussaint F, Hornung A, Heinzerling L, Berking C, Schliep S Conference contribution COVID-19 und Auswirkungen auf dermatologische und allergologische Erkrankungen (2020) Buhl T, Beissert S, Gaffal E, Goebeler M, Hertl M, Mauch C, Reich K, et al. Journal article, Review article COVID-19 und Immunregulation – von grundlegenden und translationalen Aspekten zu klinischen Implikationen (2020) Schön MP, Berking C, Biedermann T, Buhl T, Erpenbeck L, Eyerich K, Eyerich S, et al. Journal article, Review article Infektiöse Reisedermatosen (2020) Rongisch R, Schmidt E, Deresz N, Deresz K, Schöfer H, Schäkel K, Jakob T, et al. Journal article Side effect management during immune checkpoint blockade using CTLA-4 and PD-1 antibodies for metastatic melanoma - an update (2020) Kaehler KC, Hassel JC, Heinzerling L, Loquai C, Thoms KM, Ugurel S, Zimmer L, Gutzmer R Journal article Nebenwirkungsmanagement bei Immun-Checkpoint-Blockade durch CTLA-4- und PD-1-Antikörper beim metastasierten Melanom – ein Update (2020) Kähler KC, Hassel JC, Heinzerling L, Loquai C, Thoms KM, Ugurel S, Zimmer L, Gutzmer R Journal article S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid: 2019 update (2020) Schmidt E, Sticherling M, Sárdy M, Eming R, Goebeler M, Hertl M, Hofmann SC, et al. Journal article S2k-Leitlinie zur Therapie des Pemphigus vulgaris/foliaceus und des bullösen Pemphigoids: 2019 Update (2020) Schmidt E, Sticherling M, Sárdy M, Eming R, Goebeler M, Hertl M, Hofmann SC, et al. Journal article